What Is a Peptide Bond? How Amino Acids Link Into Peptides, Polypeptides and Proteins

Every peptide and every protein on Earth is held together by the same small link, repeated over and over. It is only a handful of atoms, yet it can sit unbroken in pure water for years, your cells make it with a machine whose working heart turned out to be RNA, and chemists needed a Nobel Prize-winning idea to build it reliably in a flask. That link is the peptide bond.

Our plain-English guide What Are Peptides? explains that peptides are short chains of amino acids. This guide zooms in on the joint between the links: how a peptide bond forms, why it is flat and rigid, how chains are written, where the lines fall between peptide, polypeptide and protein, how enzymes cut the bond, how chemists build and protect it, and how mass spectrometry snaps it on purpose to read a sequence. Along the way we use real molecules from our research peptides as examples. Every Crown Peptides compound mentioned here is sold strictly for laboratory research use only, and this guide is written for readers interested in the science.

What Is a Peptide Bond, in Plain English?

The short answer

A peptide bond is the chemical link that joins one amino acid to the next. Every amino acid has two "hands": an amino group (a nitrogen carrying hydrogens) at one end and a carboxyl group (a carbon carrying two oxygens) at the other. A peptide bond forms when the carboxyl hand of one amino acid grips the amino hand of the next, creating a strong covalent bond between a carbon and a nitrogen.

Repeat that step and you get a chain. The backbone of every peptide, from the three-amino-acid GHK-Cu Research Peptide to a protein thousands of units long, is this same bond repeated, with each amino acid's side chain sticking out like a charm on a bracelet.

Is there such a thing as a "polypeptide bond"?

It is a fair question. Strictly, there is no separate bond with that name. A polypeptide is a long chain of amino acids, and the links holding it together are ordinary peptide bonds. A straight chain of 100 amino acids contains 99 of them.

Why it is also called an amide bond

Chemists group bonds into families, and the peptide bond belongs to the amides: any link in which a carbon double-bonded to an oxygen is joined to a nitrogen. "Amide bond" is the general chemical name; "peptide bond" is the name used when the amide joins two amino acids.

How Is a Peptide Bond Formed? The Reaction That Gives Off Water

Two amino acids, one molecule of water

When the carboxyl group of one amino acid meets the amino group of another, the carboxyl gives up an OH and the amino group gives up an H. Those three atoms leave together as one molecule of water, and the carbon and nitrogen left behind bond to each other. Because water is released, chemists call this a condensation reaction. Two glycines, each about 75 daltons (the unit of molecular mass), join to make glycylglycine at about 132 daltons, with the missing 18 walking off as water.

Every time a chain grows by one amino acid, it gains that amino acid's mass minus 18, its "residue mass", which is the number mass spectrometry uses to read sequences.

Why amino acids do not join on their own

Dissolve amino acids in water and wait, and almost nothing happens. In water the balance actually favours breaking peptide bonds rather than making them, so something has to supply energy. In cells, that is the ribosome, working with amino acids pre-loaded onto transfer RNA. In the laboratory, it is an "activating" reagent that makes the carboxyl group eager to react.

Glutathione: a peptide bond with a twist

The tripeptide in our Glutathione Research Peptide is glutamate, cysteine and glycine, but its first link uses the carboxyl on glutamate's side chain (the "gamma" carboxyl) instead of the usual backbone one. It is built by two dedicated enzymes rather than the ribosome, and taken apart by a specialised enzyme, gamma-glutamyl transpeptidase, as set out in Alton Meister's classic review (PMID: 6137189). Its wider story is in why glutathione is called the master antioxidant.

The Structure of the Peptide Bond: Why It Is Flat, Rigid and Nearly Always Trans

On paper, the carbon-nitrogen link looks like an ordinary single bond that should spin freely like an axle. It does not, and that one fact shapes every peptide and protein in existence.

Part single bond, part double bond

The electrons in the peptide bond are shared across three atoms: the oxygen, the carbon and the nitrogen. The nitrogen's spare pair of electrons leans towards the carbon, so the carbon-nitrogen link behaves partly like a double bond. This is called partial double-bond character, and because a double bond cannot twist without breaking, the peptide bond is locked flat.

Linus Pauling and Robert Corey built on this flat, rigid peptide unit when, with Herman Branson, they proposed the alpha-helix in 1951, one of the two great shapes protein chains fold into (PMID: 14816373). Pauling received the 1954 Nobel Prize in Chemistry for his research into the nature of the chemical bond.

Six atoms in a plane, and two joints that rotate

Six atoms sit in one flat plane: the two alpha carbons (the central carbon of each amino acid), the carbonyl carbon and its oxygen, and the nitrogen and its hydrogen. Picture a chain of flat playing cards joined at their corners. The cards cannot bend, but each corner, at the alpha carbon, has two bonds that can swivel. In 1963, G. N. Ramachandran and colleagues worked out which combinations of those two angles are possible without atoms colliding (PMID: 13990617). Most are forbidden, and that restriction is what lets chains fold into predictable helices and sheets.

Cis and trans: the rare exception

Because the bond is flat, the alpha carbons either side can sit in only two arrangements: trans, on opposite sides, or cis, on the same side, which crowds neighbouring side chains. Trans wins almost every time. When a University of Georgia team counted peptide bonds across the Brookhaven Protein Data Bank, only 17 of 31,005 ordinary peptide bonds, or 0.05%, were cis. For bonds in front of the amino acid proline, 99 of 1,534, or 6.5%, were cis, and they sat mainly in bends and turns (PMID: 2370664).

Proline, the amino acid that bends the rules

Proline's side chain loops back and bonds to its own backbone nitrogen, forming a ring. That makes the cis and trans forms much closer in energy, so proline bonds sit in the cis form far more often than any other, and the switch between the two is slow. In 1975, John Brandts and colleagues proposed that a puzzling slow phase seen when proteins unfold and refold was caused by proline bonds switching between cis and trans (PMID: 241393). Nature even evolved enzymes to speed the flip: in 1989, Gunter Fischer's group showed that peptidyl-prolyl cis-trans isomerase is probably identical to cyclophilin, the protein that binds the cyclic peptide drug cyclosporin A (PMID: 2492638).

Reading a Peptide Chain: N-Terminus, C-Terminus and How Sequences Are Written

Every chain has a front and a back

Because each peptide bond joins a carboxyl to an amino group, a chain always has two different ends. The first amino acid keeps a free amino group: the N-terminus. The last keeps a free carboxyl group: the C-terminus. Chains are always written from N to C, left to right, the same direction the ribosome builds them.

Three-letter and one-letter codes

The Semax Research Peptide is Met-Glu-His-Phe-Pro-Gly-Pro in three-letter code (PMID: 22096989), or MEHFPGP in one-letter code. KPV is named after its sequence, Lys-Pro-Val (PMID: 18061177), and the Khavinson peptide in our Pinealon Research Peptide appears in the literature as the EDR peptide, Glu-Asp-Arg (PMID: 33396470).

Why direction matters

KPV and VPK are different molecules. Same three amino acids, same two peptide bonds, same mass, but the bonds point the other way, so the free ends sit on different residues. Sequence is order, and order is identity.

Caps at each end

The ends of a chain are where chemistry most often gets added, and nature does it too. Alpha-melanocyte-stimulating hormone, the 13-residue hormone KPV comes from, is written Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (PMID: 2555512). "Ac-" is an acetyl cap on the N-terminus; "-NH2" means the final carboxyl has become an amide. KPV is its last three residues.

Reading sequences was once painstaking. In the early 1950s, Frederick Sanger in Cambridge broke insulin chains into small pieces by partial hydrolysis and pieced the overlapping fragments together like a jigsaw (PMID: 14886310), work that earned him the 1958 Nobel Prize in Chemistry.

Peptide vs Polypeptide vs Protein: Where Are the Lines?

The honest answer is that the lines are conventions, not laws of nature: all three are built from exactly the same bond.

Peptide, polypeptide or protein: which word when?

Usually a peptide is not a protein, though they are close relatives. A peptide is a short chain of amino acids. A protein is a long chain, or several chains, folded into a specific three-dimensional shape that it usually needs in order to work. Proteins are made of polypeptides, and polypeptides are made of peptide bonds.

Short chains such as GHK, KPV and Semax have their own labels, as our What Are Peptides? guide sets out. At the longer end, the words usually mean:

• Polypeptide: a longer unbranched chain, from a few dozen amino acids upwards.
• Protein: one or more polypeptides folded into a working structure, commonly said to start around 50 amino acids.

One official line: the FDA's 40 amino acids

Regulators have had to draw a firm line. In the United States, a rule that took effect on 23 March 2020 defines a protein as any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size (US Federal Register). Insulin counts as a protein, because its chains of 21 and 30 amino acids are added together to give 51, while a 29-residue chain like our Sermorelin Research Peptide falls on the peptide side. Chemically, though, residue 40 and residue 41 are joined by exactly the same bond. The more meaningful difference is folding: longer chains can fold back on themselves into helices and sheets, held by hydrogen bonds between peptide groups, while many short peptides stay flexible.

How Living Cells Make Peptide Bonds: The Ribosome's Secret

Your cells make peptide bonds constantly in the ribosome, which reads messenger RNA three letters at a time and adds the matching amino acid, one peptide bond per step. The part that forms the bond is the peptidyl transferase centre: the growing chain sits on one transfer RNA, the next amino acid arrives on another, the ribosome brings the incoming amino group up against the chain's carboxyl end, and the bond forms.

The surprise: RNA does the chemistry

Most scientists assumed one of the ribosome's dozens of proteins made the bond. In 1992, Harry Noller's group showed that ribosomes from the heat-loving bacterium Thermus aquaticus kept more than 80% of their bond-forming activity after protein-digesting enzyme, detergent and vigorous phenol extraction, while an enzyme that destroys RNA abolished it (PMID: 1604315).

The proof came in 2000, when Thomas Steitz, Peter Moore and colleagues at Yale solved the large ribosomal subunit at 2.4 angstrom (a ten-billionth of a metre) resolution (PMID: 10937989) and showed that no protein side-chain atom sits closer than about 18 angstroms to the peptide bond being made. The active site is RNA: the ribosome is a ribozyme (PMID: 10937990). The 2009 Nobel Prize in Chemistry went to Venkatraman Ramakrishnan, Thomas Steitz and Ada Yonath for studies of the ribosome's structure and function. Every protein in your body is stitched together by RNA chemistry, a clue many scientists see as a fingerprint of an early "RNA world".

Breaking the Bond: Hydrolysis and the Enzymes That Cut Peptides

If the peptide bond is so stable, why do peptides break down so quickly in the body? Because biology is full of enzymes whose job is to cut it.

Stable in water, fast with enzymes

Breaking a peptide bond is the reverse of making one: water is added back across the bond, splitting it into a carboxyl and an amino group. This is hydrolysis. Without help it is remarkably slow in neutral water at room temperature, one reason freeze-dried peptides kept cold and dry hold up so well. Strong acid with heat, or the right enzyme, makes it fast. Enzymes that cut peptide bonds are called proteases or peptidases; some cut mid-chain, others nibble from the N-terminus (aminopeptidases) or the C-terminus (carboxypeptidases), and most are choosy about the amino acids either side of the bond.

DPP-4 and the two-amino-acid snip

The best-known example in peptide research is dipeptidyl peptidase-4, or DPP-4. In 1989, a Cincinnati team showed that the main enzyme breaking down human growth hormone-releasing hormone (GHRH) in plasma cuts the bond between its second and third amino acids, and that a mirror-image D-amino acid at position 1 or 2 prevented the cut (PMID: 2565342). DPP-4 removes dipeptides only from peptides with proline or alanine in second place, and a Kiel group then showed that GHRH(1-29)amide, GIP and GLP-1 were all clipped, while VIP, which starts His-Ser, was not significantly degraded (PMID: 8100523).

That single rule about one bond explains why so many peptide analogues are redesigned at the front end. Semaglutide swaps the alanine at the vulnerable position for an unnatural amino acid called Aib, a story told in Is Ozempic a Peptide? The VIP Research Peptide is a natural contrast. How fast a peptide's bonds are cut is a big part of what sets its half-life, explained in our guide to peptide half-life.

How Chemists Build Peptide Bonds in the Lab

Merrifield's idea: anchor the chain to a bead

Early chemists built peptides in solution, purifying the product after every step. In the early 1960s, Bruce Merrifield at the Rockefeller University had a simple, brilliant idea: attach the first amino acid to a tiny insoluble resin bead and add the rest one at a time, washing away excess chemicals after each step while the growing chain stays put (PMID: 3961484). Solid-phase peptide synthesis could be automated, and it won Merrifield the 1984 Nobel Prize in Chemistry "for his development of methodology for chemical synthesis on a solid matrix" (Nobel Prize facts). Almost every synthetic research peptide made today is built on his approach.

Protect, couple, wash, repeat

Reactive groups that would cause chaos are covered with temporary "protecting groups". One round goes: uncover the amino end of the chain on the bead, add the next amino acid with its carboxyl activated so the new peptide bond forms, wash, and repeat. Finally the chain is cut from the bead and the remaining protecting groups removed. On the bead, chains grow from C to N, the opposite direction to the ribosome.

Why every step's yield matters

The catch is arithmetic. In 1988, Merrifield and colleagues used mass spectrometry to count faulty by-products in model chains of 10 or 20 alanines: chains missing an amino acid (deletions) or carrying an extra one (insertions). The best method gave average deletion of only 0.036% and insertion of 0.029% per step, a stepwise yield of 99.93% (PMID: 3239745). Small errors compound: as a simple illustration, 43 coupling steps at 99.93% each leave about 97% of chains perfect, but at 99% per step only about 65%. That is why long peptides need careful synthesis and careful testing.

Armour for the Backbone: How Scientists Protect Peptide Bonds From Enzymes

Now for the really clever part. Once researchers knew which bonds enzymes attack, they began redesigning peptides to defend them, and several compounds in our range are textbook examples.

Mirror-image amino acids

Most amino acids come in two mirror-image forms, L and D, like left and right hands. Life builds almost entirely with L forms, and most enzymes grip L chains. In a Budapest study, swapping up to three amino acids at each end of a mucin peptide for their D forms kept its antibody recognition and made it highly resistant to breakdown in diluted human serum (PMID: 15630090). The Ipamorelin Research Peptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, contains two D-amino acids and the unnatural residue Aib (PMID: 9849822). The CJC-1295 (With DAC) Research Peptide is a GHRH(1-29) chain with four substitutions, including D-alanine at position 2, exactly where DPP-4 cuts; its albumin conjugates showed enhanced stability against DPP-4 (PMID: 15817669).

Capping the front end

DPP-4 and aminopeptidases need a free N-terminus to grab, so covering it takes away the handle. The Tesamorelin Research Peptide is the full 44-amino-acid human GHRH sequence with a trans-3-hexenoyl group on the first amino acid. That cap made it resistant to DPP-4 and slowed its breakdown in rat, dog and human plasma compared with natural GHRH (PMID: 17214611). The Thymosin Alpha-1 Research Peptide carries nature's own version, an acetyl cap on its first residue.

Amidating the back end

Converting the final carboxyl into an amide removes the negative charge that carboxypeptidases look for. Natural GHRH, alpha-MSH and oxytocin all end this way, as do Ipamorelin and Sermorelin. The Oxytocin Acetate Research Peptide ends in Gly-NH2, and oxytocin holds a special place in peptide-bond history: Vincent du Vigneaud won the 1955 Nobel Prize in Chemistry partly "for the first synthesis of a polypeptide hormone", and that hormone was oxytocin (Nobel Prize summary).

Closing the ring

A ring has fewer free ends for enzymes to start on and locks the backbone into a narrower range of shapes. Oxytocin forms its ring through a disulfide bridge between two cysteines. Melanocortin researchers at the University of Arizona built rings from an extra amide bond between two side chains, called a lactam bridge. In their 1989 paper, the 23-membered ring analogues were up to 100 times more potent than alpha-MSH in a lizard skin assay and showed prolonged activity, while smaller rings did not (PMID: 2555512). One compound in that series, rated at 90 times alpha-MSH, is the molecule now known as Melanotan-2: an acetyl cap, a D-amino acid, a ring and an amidated end, all in one molecule. Our Melanotan-2 Research Peptide and the PT-141 Research Peptide share the same ring and differ only at the very end: an amide on Melanotan-2, a free acid on PT-141.

Proline as a built-in shield

Remember proline's awkward ring? Most peptidases struggle to cut next to it (DPP-4 is a rare specialist), and Semax was designed around this. Its parent fragment, ACTH(4-7), was extended with Pro-Gly-Pro, and a 1986 Russian study described the result as a long-acting analogue that, unlike ACTH(5-10), showed no steroidogenic or melanocyte-stimulating activity (PMID: 3006824). Later work found that aminopeptidases trimmed Semax analogues from the front: for three of the four tested, the first product was His-Phe-Pro-Gly-Pro, with the Pro-Gly-Pro end still attached (PMID: 22096989).

When small is the story

The shortest peptides are a different case. With only two peptide bonds they offer few places to cut, although many small peptides are still broken down quickly; what sets them apart is that tiny chains can use doorways big ones cannot. In cell studies, KPV was carried into intestinal and immune cells by PepT1, a transporter built for di- and tripeptides (PMID: 18061177). The tripeptide later identified as GHK was first reported in 1973, in human serum, as a factor that prolonged the survival of normal liver cells (PMID: 4349963). For compounds like these, size itself is what makes them interesting to study.

Snapping the Bond on Purpose: How Mass Spectrometry Reads a Sequence

All of this leads to one practical question: how do you prove a vial holds the right chain, with every peptide bond in place? Weigh it, then break it.

Weighing whole molecules

A mass spectrometer measures molecules by turning them into charged particles. Large, fragile peptides were hard to ionise intact until John Fenn and colleagues at Yale developed electrospray ionisation; their landmark 1989 paper reported proteins with molecular weights up to 130,000, with no upper limit yet seen (PMID: 2675315). Fenn shared the 2002 Nobel Prize in Chemistry for this work.

Breaking the chain at its peptide bonds

To read the sequence, scientists select a peptide ion, collide it with gas and let it snap. It tends to break at the peptide bonds, giving a ladder of fragments. In 1986, Donald Hunt and colleagues described sequencing proteins this way, by tandem mass spectrometry, analysing fractions of as many as 10 to 15 peptides directly (PMID: 3462691). Fragments that keep the N-terminus are called b ions and those that keep the C-terminus y ions, under a naming system proposed by Peter Roepstorff and Johan Fohlman in 1984 and later refined by Klaus Biemann (PMID: 6525415). The gap between rungs is one residue mass, so the sequence can be read off the spectrum. Our guide to peptide testing in the UK explains how this feeds into identity testing.

The Technical Breakdown: Bond Geometry, Residue Masses and Fragment Ions

This section is for readers who want the numbers. Everything above makes sense without it.

Geometry of the peptide unit

The peptide C-N bond is about 1.33 angstroms long, between a typical C-N single bond (about 1.47) and a C=N double bond (about 1.27), reflecting its partial double-bond character. Rotation about it is described by the angle omega, close to 180 degrees for trans and 0 for cis. The two rotatable backbone angles, phi and psi, define the Ramachandran map (PMID: 13990617). The Georgia survey also found a significant number of non-planar peptide bonds, more spread than simple energy models predicted, so "flat" is a strong tendency rather than an absolute (PMID: 2370664).

Residue masses and a worked example

Each residue contributes its amino acid's mass minus one water (18.011 daltons, monoisotopic). Useful residue masses: glycine 57.021, alanine 71.037, proline 97.053, valine 99.068, leucine and isoleucine 113.084, lysine 128.095, glutamine 128.059, glutamate 129.043, methionine 131.040, histidine 137.059, phenylalanine 147.068, arginine 156.101.

For KPV: 128.095 + 97.053 + 99.068 + 18.011 = 342.227 daltons, so the singly protonated ion appears at about 343.23. Breaking the Pro-Val bond gives a b2 ion for Lys-Pro at about 226.16 and a y1 ion for valine at about 118.09; breaking the Lys-Pro bond gives a y2 ion for Pro-Val at about 215.14. Bonds on the N-terminal side of proline tend to break readily, so proline-containing peptides often show strong fragments there.

Where mass alone is not enough, and common faults

Leucine and isoleucine have identical masses; lysine and glutamine differ by only 0.036 daltons. A D-amino acid weighs exactly the same as its L form, so a flipped residue (racemisation) is caught by chromatography, not mass. Typical bond-level faults in synthetic peptides are:

• Deletion or insertion: one residue missing or extra, shifting the mass by that residue's mass (PMID: 3239745).
• Oxidation: methionine gaining an oxygen, adding about 16 daltons.
• Deamidation: asparagine or glutamine converting to aspartate or glutamate, adding about 0.98 daltons.
• Hydrolysis: a broken peptide bond, giving two fragments whose masses add up to the original plus 18.011.

Why Verified Testing Matters When Every Bond Counts

One deletion, flipped residue or broken bond can produce a near-identical but wrong molecule, so every Crown Peptides batch is checked two ways: HPLC for purity, separating closely related impurities, and mass spectrometry to confirm the chain's mass. Each batch's certificate is on our Lab Reports page, matched to the batch number on the vial, and our guide to reading a peptide certificate of analysis explains each figure.

Because water is what breaks a peptide bond, our peptides are supplied freeze-dried and stored cold and sealed (see our storage information). Weekday orders before 2pm go out the same day, UK delivery is free over £100, and if you have a question about a sequence or certificate, get in touch: we usually reply within 24 hours on business days, with WhatsApp for quicker answers.

Related Reading and Compounds

The peptide bond runs through everything we stock. These are good next steps, depending on which part of the story caught your interest.

Peptides with engineered bonds

Ipamorelin, with two D-amino acids, an Aib residue and an amidated end, shows how far a short chain can be re-engineered, while Tesamorelin, with its N-terminal cap, and CJC-1295 (With DAC), with its D-alanine and albumin-binding group, are two different answers to DPP-4. Melanotan-2 shows a lactam ring at work, and Sermorelin, the natural GHRH(1-29) sequence with no front-end protection, is the baseline those two can be compared against.

Short peptides with very few bonds

KPV, GHK-Cu and Pinealon are tripeptides with two peptide bonds each, Glutathione is the tripeptide with the gamma link, and Semax shows a Pro-Gly-Pro tail added to a hormone fragment.

Natural caps and rings

Oxytocin Acetate combines a disulfide ring with an amidated end, Thymosin Alpha-1 carries a natural acetyl cap, and VIP starts with a His-Ser pair that DPP-4 left largely alone in the Kiel study.

Further reading

Start with What Are Peptides? for the bigger picture, Peptide Half-Life Explained for how bond breakdown shapes a compound's lifetime, and How Long Do Peptides Last? for stability in the vial. Or browse our research peptides and read each sequence with fresh eyes.

The Smallest Link With the Biggest Job

Underneath every receptor, signal and result in peptide research is one flat, stubborn bond. Its rigidity lets chains fold, its proline exceptions create turns, its weak points decide how long a peptide survives, and its breaking points let a mass spectrometer read a sequence one rung at a time. Every advance in peptide design, from D-amino acids to lactam rings to a single Aib at a vulnerable position, is a conversation with the peptide bond.

Chemists are still finding new ways to shield, mimic and build the backbone, and once you can read a sequence, you never look at a peptide name the same way again. Take a look through our research peptides and see how many of the tricks in this guide you can spot.

References

• Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-60. PMID: 6137189
• Pauling L, Corey RB, Branson HR. The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain. Proc Natl Acad Sci U S A. 1951;37:205-11. PMID: 14816373
• Ramachandran GN, Ramakrishnan C, Sasisekharan V. Stereochemistry of polypeptide chain configurations. J Mol Biol. 1963;7:95-9. PMID: 13990617
• Stewart DE, Sarkar A, Wampler JE. Occurrence and role of cis peptide bonds in protein structures. J Mol Biol. 1990;214:253-60. PMID: 2370664
• Brandts JF, Halvorson HR, Brennan M. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry. 1975;14:4953-63. PMID: 241393
• Fischer G, Wittmann-Liebold B, Lang K, et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989;337:476-8. PMID: 2492638
• Shevchenko KV, V'iunova TV, Nagaev IIu, et al. Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases (in Russian). Bioorg Khim. 2011;37:475-82. PMID: 22096989
• Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134:166-78. PMID: 18061177
• Khavinson V, Linkova N, Kozhevnikova E, et al. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules. 2020;26:159. PMID: 33396470
• Al-Obeidi F, Castrucci AM, Hadley ME, et al. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem. 1989;32:2555-61. PMID: 2555512
• Sanger F, Tuppy H. The amino-acid sequence in the phenylalanyl chain of insulin. I. The identification of lower peptides from partial hydrolysates. Biochem J. 1951;49:463-81. PMID: 14886310
• US Food and Drug Administration. Definition of the Term "Biological Product". Federal Register. 21 February 2020. Federal Register
• Noller HF, Hoffarth V, Zimniak L. Unusual resistance of peptidyl transferase to protein extraction procedures. Science. 1992;256:1416-9. PMID: 1604315
• Ban N, Nissen P, Hansen J, et al. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science. 2000;289:905-20. PMID: 10937989
• Nissen P, Hansen J, Ban N, et al. The structural basis of ribosome activity in peptide bond synthesis. Science. 2000;289:920-30. PMID: 10937990
• Frohman LA, Downs TR, Heimer EP, et al. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest. 1989;83:1533-40. PMID: 2565342
• Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993;214:829-35. PMID: 8100523
• Merrifield B. Solid phase synthesis. Science. 1986;232:341-7. PMID: 3961484
• The Nobel Prize. Bruce Merrifield, Nobel Prize in Chemistry 1984: facts. nobelprize.org
• Merrifield RB, Singer J, Chait BT. Mass spectrometric evaluation of synthetic peptides for deletions and insertions. Anal Biochem. 1988;174:399-414. PMID: 3239745
• Tugyi R, Uray K, Iván D, et al. Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide. Proc Natl Acad Sci U S A. 2005;102:413-8. PMID: 15630090
• Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139:552-61. PMID: 9849822
• Jetté L, Léger R, Thibaudeau K, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146:3052-8. PMID: 15817669
• Ferdinandi ES, Brazeau P, High K, et al. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. Basic Clin Pharmacol Toxicol. 2007;100:49-58. PMID: 17214611
• The Nobel Prize. Nobel Prize in Chemistry 1955: summary. nobelprize.org
• Ponomareva-Stepnaia MA, Porunkevich EA, Skuin'sh AA, et al. Hormonal activity of the ACTH(4-10) analog: a prolonged-action stimulant of learning (in Russian). Biull Eksp Biol Med. 1986;101:267-8. PMID: 3006824
• Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243:85-7. PMID: 4349963
• Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246:64-71. PMID: 2675315
• Hunt DF, Yates JR 3rd, Shabanowitz J, et al. Protein sequencing by tandem mass spectrometry. Proc Natl Acad Sci U S A. 1986;83:6233-7. PMID: 3462691
• Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom. 1984;11:601. PMID: 6525415